IκB kinase regulation of the TPL-2/ERK MAPK pathway

Thorsten Gantke1, Srividya Sriskantharajah, Michael Sadowski

  • 1Division of Immune Cell Biology, MRC National Institute for Medical Research, Mill Hill, London, UK.

Immunological Reviews
|March 23, 2012
PubMed

Insights

The inhibitor of NF-κB (IκB) kinase (IKK) complex controls both NF-κB and ERK activation by regulating TPL-2 (tumor progression locus 2) signaling. This TPL-2 pathway is crucial for inflammation and cancer development.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways are central to innate immune responses.
  • Toll-like receptor and tumor necrosis factor receptor family stimulation activate specific MAPK pathways, including the ERK-1/2 pathway involving TPL-2.
  • The regulation of these critical signaling pathways is complex and not fully understood.

Purpose of the Study:

  • To review the regulatory role of the IκB kinase (IKK) complex in TPL-2 signaling.
  • To elucidate the mechanism by which IKK controls both NF-κB and ERK activation.
  • To examine the role of TPL-2 in inflammation and cancer and its potential as a therapeutic target.

Main Methods:

  • Review of existing laboratory data and published research.
  • Analysis of protein-protein interactions and signaling cascades involving TPL-2, NF-κB1 p105, ABIN-2, and IKK.
  • Examination of the functional consequences of TPL-2 pathway activation in cellular and disease models.

Main Results:

  • TPL-2 signaling is directly controlled by the IKK complex, indicating IKK regulates both NF-κB and ERK activation.
  • TPL-2 protein stability and activity are regulated by its complex with NF-κB1 p105 and ABIN-2.
  • IKK-mediated phosphorylation of p105 releases TPL-2 inhibition, facilitating MEK phosphorylation and subsequent NF-κB nuclear translocation.

Conclusions:

  • The IKK complex is a key regulator of TPL-2, linking innate immune receptor signaling to both NF-κB and ERK pathways.
  • TPL-2 plays a critical role in inflammation and may contribute to cancer development and progression.
  • TPL-2 represents a potential therapeutic target for inflammatory diseases and certain cancers.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...